Follow The Filings

KOD Kodiak Sciences

Kodiak Sciences earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS 1.00 — —
Rev — — —
FY2026 Q2 13 Aug EPS — -1.05 —
Rev — — —

Insider trades

Open-market buys and sales by KOD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KOD insider trades
  • $217M bought by 1 insider
  • None no sales outside a trading plan
  • $2.2M sold by 1 insider under 10b5-1 plans
  1. Baker Bros. Advisors LP Director, +5 joint filers
    Buy
    $63.4M 715,592 shares at $88.59 +3.7% to stake
    Traded Sep 28–29 Filed Sep 30
  2. Baker Bros. Advisors LP Director, +5 joint filers
    Buy
    $35M 418,323 shares at $83.58 +2.2% to stake
    Traded Sep 28 Filed Sep 30
  3. Baker Bros. Advisors LP Director, +5 joint filers
    Buy
    $58.6M 807,840 shares at $72.57 +4.4% to stake
    Traded Sep 28 Filed Sep 30
  4. John A. Borgeson CFO
    Planned sale
    $1M 30,000 shares at $34.10 12% of stake
    Traded Jun 4 Filed Jun 5
  5. John A. Borgeson CFO
    Planned sale
    $1.2M 30,000 shares at $39.92 14% of stake
    Traded Apr 2 Filed Apr 2
  6. Baker Bros. Advisors LP Director, +5 joint filers
    Buy
    $60M 2,608,696 shares at $23.00 +17% to stake
    Traded Dec 18, 2025 Filed Dec 19, 2025

Also filed in the last 12 months, not counted as buying or selling: 7 option exercises.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
SCHEDULE 13D/A —
8-K 8.01,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 5.07
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G —
8-K 2.02,9.01
10-K
8-K 8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13D/A —
8-K 8.01,9.01
424B5
424B5

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.